HSY
38
-2
VNO
59
3
GRMN
50
-2
LYB
44
-2
TAP
51
-2
TGT
50
2
TRV
64
-3
HPE
53
2
EBAY
50
-3
AEE
61
-2
SE
65
4
HON
55
-4
QRVO
33
-3
SHW
71
-2
FOX
39
2
CRM
50
-5
FLS
46
-7
WU
16
2
EMN
70
-2
PBI
62
2
HSY
38
-2
VNO
59
3
GRMN
50
-2
LYB
44
-2
TAP
51
-2
TGT
50
2
TRV
64
-3
HPE
53
2
EBAY
50
-3
AEE
61
-2
SE
65
4
HON
55
-4
QRVO
33
-3
SHW
71
-2
FOX
39
2
CRM
50
-5
FLS
46
-7
WU
16
2
EMN
70
-2
PBI
62
2
Financhill
Back

PROCEPT BioRobotics 10K Form

Buy
53

PRCT
PROCEPT BioRobotics

Last Price:
82.73
Seasonality Move:
-0.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRCT News And Ratings

See the #1 stock for the next 7 days that we like better than PRCT

PRCT Financial Statistics

Sales & Book Value

Annual Sales: $136.19M
Cash Flow: $-16.78M
Price / Cash Flow: 0
Annual Sales: $4.85
Price / Book: 17.13

Profitability

EPS (TTM): -2.06000
Net Income (TTM): $-103.71M
Gross Margin: $71.05M
Return on Equity: -41.42%
Return on Assets: -27.95%

PROCEPT BioRobotics Earnings Forecast

Key PROCEPT BioRobotics Financial Ratios

  • The Gross Profit Margin over the past 5 years for PRCT is 52.17%.
  • The Selling, General & Administrative Expenses for PRCT have been equal to 96.76% of Gross Profit Margin.
  • The Research & Development expenses have been 35.57% of Revenue.
  • The Interest Expense is -3.77% of Operating Income.
  • The Net Earning history of PRCT is -77.76% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

PROCEPT BioRobotics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: PRCT
Website: procept-biorobotics.com

Debt

Debt-to-Equity Ratio: 0.2
Current Ratio: 7.51
Quick Ratio: 6.37

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRCT Technical Analysis vs Fundamental Analysis

Buy
53
PROCEPT BioRobotics (PRCT) is a Buy

Is PROCEPT BioRobotics a Buy or a Sell?